DELTICOM-AG
26.11.2015 11:47:38 CET | Business Wire | Press release
It’s buzzing on our roads and motorways. In the first nine months of 2015, there were almost 18% more trucks and commercial vehicles registered in the UK than last year.* In light of these figures, it is worth doing some forward planning and invest wisely. In the UK, the number of road traffic accidents leading to personal injury involving goods vehicles rose in 2014 by 6% in comparison to the previous year.** New tyres can make an absolutely critical contribution to safe mobility.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151126005106/en/
That’s why safety experts advise transport companies and business people who run a small fleet to service their vehicles intensively. Not only does this contribute to increased working life, it also makes an important contribution to road safety. During long, dark European winters with constantly changing weather conditions, having perfect grip increases the mobility of goods transporters and businesses by a significant multiple. “It’s worth investing in fresh tyres , not only when they’re worn, or you have to change because of the season. Very often, every millimetre counts, such as in tricky traffic situations. With new tyres , both driver and business owner are well equipped. Over the last few years, we have specialised in supplying a wide range of complete winter tyres size 17.5”, as these tyres, in particular, cover the whole spectrum of small fleet operators. Business people can count on our online car tyre shops , with excellent availability of 17.5” tyres in all price/performance categories” , says Andreas Wilmsmeier, Key-Account Manager Truck and Commercial Tyres EU at Delticom . He continues: “Our customers benefit from a wide variety of high-quality tyres. More and more transport experts are on the road in the best possible way with our own brand Goodride. Goodride truck tyres are characterised by a high level of reliability and economy”.
At the Delticom online stores for dealers and garages attractive packages are offered to all kind of businesses, no matter if small or large. With a winter discount promotion in December the online tyre dealer supports the safety of its customers. For each purchased truck tyre 10 euro discount will be granted per at the online shops for professional customers in Germany , Austria , Switzerland , France , Italy , Spain and the Netherlands (in Switzerland 10 CHF). The winter discount promotion starts at 1st of December and ends on the 31st of December 2015.
Buying tyres online provide numerous benefits: the stores are “open all hours” - 365 days a year, 24/7, thus saving that valuable resource - time. In addition, business owners can increase efficiency by benefitting from low-cost deals all year round. The truck / commercial vehicle team at Delticom can also offer personal advice if required. Within the UK, the tyres are generally dispatched in 2 - 4 days.
* Source: www.smmt.co.uk
** Source: www.gov.uk
Tyres for trucks, light trucks and commercial vehicles you can find in the online shops for:
- Dealers: www.yourtyres.co.uk , www.autoreifenonline.de , www.autoreifenonline.at , www.autoreifenonline.ch , www.pneus-auto.fr , www.pneumatici123.it , www.neumaticos123.com , www.porbanden.nl
- Fleet clients: www.fleettyres24.co.uk , www.flotten24.de , www.flotten24.at , www.flotten24.ch , www.flotte24.fr , www.flotta24.it , www.fleet24.nl
Truck tyres also available at the online shops for consumers : www.mytyres.co.uk/Truck-Tyres , www.reifendirekt.de , www.reifendirekt.at , www.reifendirekt.ch/LKW-Reifen.html , www.123pneus.fr/pneus_camion , www.gommadiretto.it/Pneumatici_autocarri , www.neumaticos-online.es/Neumaticos_camiones , www.autobandenmarkt.nl/Vrachtwagenbanden
Tyre tests: www.tyretests.com
Information about the company: www.delti.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20151126005106/en/
Contact:
Delticom AG
Susanne Kindor-d’Unienville
T: +49 511 93634852
E-Mail:
susanne.kindor@delti.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom